Publications (58) Felipe Pérez García publications

filter_list

2026

  1. Affinity peptide-based magnetic micromotors for rapid, selective, ultra-sensitive, and reliable quantification of SARS-CoV-2 spike protein in microliter-scale nasopharyngeal and plasma samples from infected patients

    Biosensors and Bioelectronics, Vol. 292

2025

  1. Longitudinal recovery trajectories and ventilatory modalities in COVID-19 acute respiratory distress syndrome survivors

    ERJ Open Research, Vol. 11, Núm. 2

  2. Mechanical power is not associated with mortality in COVID-19 mechanically ventilated patients

    Annals of Intensive Care, Vol. 15, Núm. 1

  3. Outcomes and predictors of mortality in patients with severe COVID-19 and COPD admitted to ICU: A multicenter study

    Anaesthesia Critical Care and Pain Medicine, Vol. 44, Núm. 5

  4. Prevalence and patterns of antiretroviral resistance in HIV-infected Latin American asylum seekers

    Scientific Reports, Vol. 15, Núm. 1

  5. Prevalence and risk factors of active hepatitis C infection among at-risk migrant populations in Madrid, Spain, 2019 to 2023

    Eurosurveillance, Vol. 30, Núm. 29

  6. Spanish nationwide survey of Pseudomonas aeruginosa cefiderocol antimicrobial susceptibility and resistance genomics

    International Journal of Antimicrobial Agents, Vol. 66, Núm. 4

2024

  1. Clustering COVID-19 ARDS patients through the first days of ICU admission. An analysis of the CIBERESUCICOVID Cohort

    Critical Care, Vol. 28, Núm. 1

  2. Decrease in active hepatitis C infection among people who use drugs in Madrid, Spain, 2017 to 2023: a retrospective study

    Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, Vol. 29, Núm. 29

  3. Prevalence of HCV Infection Among People Experiencing Homelessness in Madrid, Spain

    JAMA network open, Vol. 7, Núm. 10, pp. e2438657

2023

  1. A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study

    Respiratory Research, Vol. 24, Núm. 1

  2. A deficient immune response to SARS-CoV-2 in the nasopharynx is associated with severe COVID-19 pneumonia

    International Journal of Infectious Diseases, Vol. 134, pp. 126-132

  3. Clinical Evolution and Risk Factors in Patients Infected during the First Wave of COVID-19: A Two-Year Longitudinal Study

    Tropical Medicine and Infectious Disease, Vol. 8, Núm. 7

  4. Comparison of chemiluminiscence versus lateral flow assay for the detection of Helicobacter pylori antigen in human fecal samples

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 42, Núm. 8, pp. 959-962

  5. Driving pressure and adjunctive therapies in pulmonary sequelae of COVID-19 patients under invasive ventilation

    Intensive Care Medicine

  6. Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study

    The Lancet Microbe, Vol. 4, Núm. 6, pp. e431-e441

  7. Hepatitis E Virus Seroprevalence is Associated with Neurodegenerative Disorders in Older People with Dementia: A Case-Control Study

    The Journal of infectious diseases, Vol. 227, Núm. 7, pp. 873-877

  8. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215

  9. Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients

    Intensive Care Medicine, Vol. 49, Núm. 8, pp. 934-945

  10. Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis

    The Lancet Regional Health - Europe, Vol. 34